greekenglish
     Home arrow Ophthalmology Clinic        

Login Form

Username

Password

Remember me
Password Reminder
No account yet? Create one
Ophthalmology Clinic
Clinical Work

 


STATISTICAL DATA 2019                                                                                                                                                            

 NUMBER OF BEDS: 23

NURSES: 2423

DAYS OF HOSPITALIZATION: 4864

COMPLETENESS OF CLINIC: 102,65%

AVERAGE TIME OF HOSPITALITY: 2,033 DAYS

SURGICAL PROCEDURES: 919

CYSTESCOSPIES: 799

CORRECTIVE PROSTATE BIOPSIES: 196

URODYNAMIC STUDIES: 35

PERCUTANEOUS Nephrostomies: 54

EXAMINERS AT THE T.E.P: 1987

EXAMINERS AT T.E.I: 2147

EXOSOMAL LITHOTRAPIES: 751

 


STATISTICAL DATA 2020

 NUMBER OF BEDS: 23

NURSES: 2137

DAYS OF HOSPITALIZATION: 4015

COMPLETENESS OF CLINIC: 84,52%

AVERAGE TIME OF HOSPITALITY: 1,8788 DAYS

SURGICAL PROCEDURES: 742

CYSTESCOSPIES: 825

CORRECTIVE PROSTATE BIOPSIES: 182

URODYNAMIC STUDIES: 31

PERCUTANEOUS Nephrostomies: 44

EXAMINERS AT THE T.E.P: 1306

EXAMINERS AT T.E.I: 1393

EXOSOMAL LITHOTRAPIES: 595

 


STATISTICAL DATA 2021

 NUMBER OF BEDS: 23

NURSES: 1423

DAYS OF HOSPITALIZATION: 3290

COMPLETENESS OF CLINIC: 68,13%

AVERAGE TIME OF HOSPITALITY: 2,58 DAYS

SURGICAL PROCEDURES: 751

CYSTESCOSPIES: 916

CORRECTIVE PROSTATE BIOPSIES: 198

URODYNAMIC STUDIES: 68

PERCUTANEOUS Nephrostomies: 53

EXAMINERS AT THE T.E.P: 1886

EXAMINERS AT T.E.I: 1384

EXOSOMAL LITHOTRAPIES: 578

 


STATISTICAL DATA 2022

 NUMBER OF BEDS: 23

NURSES: 925

DAYS OF HOSPITALIZATION: 2908

COMPLETENESS OF CLINIC: 61,26%

AVERAGE TIME OF HOSPITALITY: 3,1437 DAYS

SURGICAL PROCEDURES: 847

CYSTESCOSPIES: 1274

CORRECTIVE PROSTATE BIOPSIES: 215

URODYNAMIC STUDIES: 50

PERCUTANEOUS Nephrostomies: 63

EXAMINERS AT THE T.E.P: 1902

EXAMINERS AT T.E.I: 1651

EXOSOMAL LITHOTRAPIES: 562

 


STATISTICAL DATA 2023

 NUMBER OF BEDS: 23

NURSES: 1045

DAYS OF HOSPITALIZATION: 3273

COMPLETENESS OF CLINIC: 69,09%

AVERAGE TIME OF HOSPITALITY: 3,13 DAYS

SURGICAL PROCEDURES: 997

CYSTESCOSPIES: 1187

CORRECTIVE PROSTATE BIOPSIES: 409

URODYNAMIC STUDIES: 63

PERCUTANEOUS Nephrostomies: 43

EXAMINERS AT THE T.E.P: 2009

EXAMINERS AT T.E.I: 1619

EXOSOMAL LITHOTRAPIES: 551

 


 

Papers in international journals

 

1. Spontaneous perirenal hemorrhage: A 10-year experience at our institution.G.Daskalopoulos,I.Karyotis,I.Heretis,P.Anezinis,E.Mavromanolakis,D.Delakas Internat Urol & Nephrol 2004,36: 15-19.


2. Electrothermal bipolar coagulation for radical prostatectomies and cystectomies: A preliminary case-controlled study. G.Daskalopoulos, I.Karyotis, I.Heretis, P.Anezinis, D.Delakas Internat Urol & Nephrol 2004,36: 181-185.


3. Deregulation of p73 isoform equilibrium in benign prostate hyperplasia and prostate cancer. D.Arvanitis,E.Lianos,N.Soulitzis,D.Delakas,D.Spandidos

Oncology Rep 2004,12:1131-1137.


4. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1,EGF and IGF1 in prostate cancer and benign prostatic hyperplasia. N.Soulitzis, I.Karyotis, D.Delakas, D.A. Spandidos Inter J of Oncol 2006,29: 305-314.


5. Μediterranean diet,mononsuturated:saturated`fat ratio and low prostate cancer risk. A myth or a reality? K.Stamatiou,D.Delakas,F.Sofras Min Urol & Nefrol 2007,59(1):59-66.


6. Pheochromocytoma of the urinary bladder: Report of two cases and review of the literature. A.Siatelis, C.Konstantinidis, D.Volanis, P.Melidis, V.Leontara, E.Thoma, Tsagli, D.Delakas Min Urol & Nefrol 2008,60:1-4.


7. Post-coital high-flow priapism treated with superselective microcoil embolization. Konstantinidis C, Gekas A, Papatsoris A, KartsaklisP, MourikisD, Delakas D,Sofikitis N Gaz Med Ital  2010,169:19-21


8. Urothelial carcinoma of the sarcomatoid variant in a young patient with spina bifida:a case report and review of the literature. M Nomikos,P Phillipou,C Glava,D Delakas Cases J 2009,2:9381


9. Transrectal Ultrasound-Guided Needle Aspiration of a prostatic Abscess.

M Nomikos,I Karyotis,D Volanis,D Delakas. UroToday Inter J 2009,2(6):1944


10. Environmental factors and genetic susceptibility promote urinary bladder cancer D Volanis,T Kadiyska,A Galanis,D Delakas, S Logotheti. Tox Lett 2010,15:193(2):131-7


11. Mutational Analysis of the BRAF gene in transitional cell carcinoma of the bladder. I Boulalas,A Zaravinos,D Delakas,D Spandidos Inter J Biol Mark 2009,24(1):17-21


12. Safety of Ultrasound-Guided Transrectal Extended Prostate Biopsy in Patients Receiving Low-dose Aspirin. I Kariotis,P Philippou,D Volanis,E Serafetinides,D Delakas. Inter Br J Urol 2010,36(3):308-16


13. Implication of RAF and RKIP Genes in Urinary Bladder Cancer.

A Zaravinos,M Chatziioannou,G Lambrou,I Boulalas, D Delakas, D Spandidos 

Pathol Oncol Res 2011, 17(2):181-90


14. Plasmacytoid Urothelial Carcinoma of the Bladder: A Rare Malignancy

P Philippou,I Kariotis,D Volanis,A Ploumidis,D Delakas 

Urol Inter 2011,86(3):370-2


15. Prospective Comparative Study of Endoscopic Management OF Bladder Lithiasis:Is Prostate Surgery a Necessary Adjunct? 

P Philippou,D Volanis,I Kariotis,E Serafetinides,D Delakas 

Urol 2011,78(1);43-7


16. Statins and prostate cancer:Molecular and clinical aspects

G Papadopoulos,D Delakas,L Nakopoulou,T Kassimatis 

Eur JC 2011,47(6);819-30


17. Activation of RAS Family Genes in Urothelial Carcinoma

I Boulalas,A Zaravinos,I Karyotis,D Delakas,D Spandidos 

J Urol 2009,181(5):2312-9

18. Activation of RAS Family Genes in Urothelial Carcinoma

I Boulalas,A Zaravinos,I Karyotis,D Delakas,D Spandidos 

J Urol 2009,181(5):2312-9


19. Identification of common differentially expressed genes in urinary bladder cancer

A Zaravinos,G Lambrou,I Boulalas,D Delakas,D Spandidos

PLos ONE 2011,6(4):e18135-1-28


20. Spotlight on differentially expressed genes in urinary bladder cancer

A Zaravinos,G Lambrou,D Volanis,D Delakas,D Spandidos

PLos ONE 2011,5(6):4,e 18255


21. Implication of RAF and RKIP Genes in Urinary Bladder Cancer

Zaravinos,M. Chatziioannou,G. Lambrou,I. Boulalas,D. Delakas, D.A. Spandidos

Pathol Oncol Res 2011,17:181-190


22. mRNA  expression of G(1)-phase cell cycle regulatory molecules in bladder cancer.

Pantazis E,Soulitzis N,Soufla G,Karyotis I,Delakas D,Spandidos DA

J BUON 2011,16(2):323-30


23. Expression profile of Rho kinases in urinary bladder cancer

Volanis D, Zaravinos A, Kadiyska T,Delakas D,Spandidos DA

J BUON 2011,16(3):511-521.


24. A Computational model for tumor cell membrane tolerance and rigidy limits

G Lambrou,A Zaravinos,M Adamaki,D Delakas,S Vlahopoulos

Proccedings of 10th Inter Workshop on Biomedical Engineering.Kos,5-7 Oct 2011


25. Molecular mechanisms in urinary bladder carcinogenesis

Volanis D, Papadopoulos G,Doumas K, Gkialas I,Delakas D

J Buon 2011;16(4):589-601


26. Post-esw lithotripsy residual stone fragments:clinical significance and management, Porfyris,D Delakas

Scand J Urol & Nephrol 2012;early online,1-8

 

 

post

fdf

VC Dietetic
WHR


To determine if you have a healthy waist to hip ratio, use a measuring tape to measure the circumference of your hips at the
widest part of your buttocks. Then measure your waist at the smaller circumference of your natural waist, usually just above the
belly button.

To determine the ratio, divide your waist measurement by your hip measurement.
Research shows that people with "apple-shaped" bodies (with more weight around the waist)face more health risks than those
with "pear-shaped" bodies who carry more weight around the hips.

<< Start < Previous 11 12 13 14 15 16 17 18 19 20 Next > End >>

Results 154 - 162 of 327
IT Asklepieio Voulas
Number of Visitors